Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,127.79 +63.59 (+1.26%) Dow
38,675.68 +449.98 (+1.18%) Nasdaq
16,156.33 +315.33 (+1.99%) Bitcoin USD
63,653.01 -37.39 (-0.06%) CMC Crypto 200
1,368.49 +55.86 (+4.25%)
CTLT May 2024 55.000 call
| Previous close | 2.5000 |
| Open | 2.5000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 55.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.5000 - 2.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 12 |
- Reuters SG
Deals of the day-Mergers and acquisitions
** Sony Pictures Entertainment and private equity firm Apollo Global Management on Wednesday submitted a $26 billion offer for Paramount Global but have yet to receive a response as of Friday, according to a person familiar with the matter. ** L Catterton, a private equity firm backed by French luxury group LVMH , said on Friday it had succeeded in securing enough shares in luxury shoe maker Tod's to take it private in agreement with the Italian group's main shareholder, the Della Valle family.
ReutersUS FTC seeks more information on Novo Nordisk parent-Catalent deal
Catalent said on Friday the companies were in the process of gathering information to respond to the U.S. Federal Trade Commission's request received on May 2. Novo Holdings in February agreed to buy Catalent to boost output of the popular weight-loss drug Wegovy.
- Reuters
UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
The U.S. FTC has sought more information on Novo Nordisk parent's $16.5 billion bid for contract drug manufacturer Catalent, weeks after an application to the regulator was refiled for approval of the deal. Catalent said on Friday the companies were in the process of gathering information to respond to the U.S. Federal Trade Commission's request received on May 2. Novo Holdings in February agreed to buy Catalent to boost output of the popular weight-loss drug Wegovy.
